Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 and the health of people who use drugs: What is and what could be?
Jason Grebely, Magdalena Cerdá, Tim Rhodes
International Journal of Drug Policy (2020) Vol. 83, pp. 102958-102958
Open Access | Times Cited: 83

Showing 26-50 of 83 citing articles:

Exploring the impact of the COVID-19 pandemic on syringe services programs in rural Kentucky
Jennifer L. Glick, Suzanne M. Grieb, Samantha J. Harris, et al.
Harm Reduction Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 13
Implementing drug checking as an illicit drug market intervention within the supply chain in a Canadian setting
Bruce Wallace, Thea van Roode, Piotr Burek, et al.
Drugs Education Prevention and Policy (2022) Vol. 30, Iss. 5, pp. 443-452
Open Access | Times Cited: 13
Futures-oriented drugs policy research: Events, trends, and speculating on what might become
Tim Rhodes, Kari Lancaster
International Journal of Drug Policy (2021) Vol. 94, pp. 103332-103332
Closed Access | Times Cited: 17
Everywhere and for everyone: proportionate universalism as a framework for equitable access to community drug checking
Bruce Wallace, Thea van Roode, Piotr Burek, et al.
Harm Reduction Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 12
Spotting as a risk mitigation method: A qualitative study comparing organization-based and informal methods
Melissa Perri, Adrian Guţă, Nat Kaminski, et al.
International Journal of Drug Policy (2022) Vol. 111, pp. 103905-103905
Closed Access | Times Cited: 11
Adapting to changing risk environments: examining overdose risk and socio-spatial patterns of unstably housed people who use drugs during converging public health crises
Alexandra B. Collins, Jacqueline Goldman, Sarah Edwards, et al.
Drugs Education Prevention and Policy (2024), pp. 1-11
Closed Access | Times Cited: 2
Telemedicine and decentralized hepatitis C treatment as a strategy to enhance retention in care among people attending drug treatment centres
Dalia Morales‐Arráez, Alberto Hernández-Bustabad, María Jesús Medina-Alonso, et al.
International Journal of Drug Policy (2021) Vol. 94, pp. 103235-103235
Closed Access | Times Cited: 15
Covid-19 and child criminal exploitation in the UK: implications of the pandemic for county lines
Ben Brewster, Grace Robinson, Bernard W. Silverman, et al.
Trends in Organized Crime (2021) Vol. 26, Iss. 2, pp. 156-179
Open Access | Times Cited: 15
How has the COVID-19 epidemic affected the risk behaviors of people who inject drugs in a city with high harm reduction service coverage in Vietnam? A qualitative investigation
Nguyễn Thu Trang, Hoang Thi Giang, Duc Nguyen, et al.
Harm Reduction Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 10
Digital Interventions to Save Lives From the Opioid Crisis Prior and During the SARS COVID-19 Pandemic: A Scoping Review of Australian and Canadian Experiences
Andrea Donnell, Chandana Unnithan, Jessica Tyndall, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 10
What's in Stock? Drug drought anticipation during COVID-19 among people who use drugs and service providers
Maj Nygaard‐Christensen, Thomas Friis Søgaard
International Journal of Drug Policy (2023) Vol. 117, pp. 104048-104048
Open Access | Times Cited: 6
Residence in urban or rural counties in relation to opioid overdose mortality among Kentucky hospitalizations before and during the COVID-19 pandemic
Lyndsey Blair, Jeffrey T. Howard, Nicholas C. Peiper, et al.
International Journal of Drug Policy (2023) Vol. 119, pp. 104122-104122
Closed Access | Times Cited: 6
Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study
Anna Conway, Heather Valerio, Amy Peacock, et al.
International Journal of Drug Policy (2021) Vol. 96, pp. 103421-103421
Closed Access | Times Cited: 14
Preventing Overdose Using Information and Data from the Environment (PROVIDENT): protocol for a randomized, population‐based, community intervention trial
Brandon D. L. Marshall, Nicole Alexander‐Scott, Jesse L. Yedinak, et al.
Addiction (2021) Vol. 117, Iss. 4, pp. 1152-1162
Open Access | Times Cited: 14
Assessing the impact of simplified HCV care on linkage to care amongst high-risk patients at primary healthcare clinics in Malaysia: a prospective observational study
Jessica Markby, Sonjelle Shilton, Xiaohui Sem, et al.
BMJ Open (2021) Vol. 11, Iss. 12, pp. e055142-e055142
Open Access | Times Cited: 14
General hospital admissions in young and middle-aged people who use psychoactive substances: Impact of Covid-19 lockdowns
Justine Perino, Hanta Ramaroson, Natalie Ong, et al.
International Journal of Drug Policy (2023) Vol. 118, pp. 104082-104082
Open Access | Times Cited: 5
Pandemic lockdown as policy window for street-level innovation of health and substitution treatment services for people who use drugs
Maj Nygaard‐Christensen, Esben Houborg
Drugs Habits and Social Policy (2023) Vol. 24, Iss. 3, pp. 232-245
Open Access | Times Cited: 5
Use of sustained release dextroamphetamine for the treatment of stimulant use disorder in the setting of injectable opioid agonist treatment in Canada: a case report
Heather Palis, Scott Macdonald, Jennifer Jun, et al.
Harm Reduction Journal (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 12
The Change in Psychoactive Substance Consumption in Relation to Psychological Stress During the Covid-19 Pandemic in Uruguay
Paúl Ruiz, Florencia Semblat, Ricardo Marcos Pautassi
Sultan Qaboos University medical journal (2021)
Open Access | Times Cited: 12
COVID-19 economic impact payments and opioid overdose deaths
Jon E. Sprague, Arthur B. Yeh, Qizhen Lan, et al.
International Journal of Drug Policy (2022) Vol. 102, pp. 103608-103608
Open Access | Times Cited: 8
Political partisanship and stigma against people who use drugs in opinions about allocating COVID-19 prevention resources to vulnerable populations
Kristin E. Schneider, Deborah Wilson, Lauren Dayton, et al.
International Journal of Drug Policy (2021) Vol. 95, pp. 103301-103301
Open Access | Times Cited: 11
Understanding the Impacts of Novel Coronavirus Outbreaks on People Who Use Drugs: A Systematic Review to Inform Practice and Drug Policy Responses to COVID-19
Alison Munro, Hazel Booth, Nicola Gray, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 16, pp. 8470-8470
Open Access | Times Cited: 11
Safer in care: A pandemic-tested model of integrated HIV/OUD care
Ellen Eaton, Ashutosh Tamhane, Wesli H. Turner, et al.
Drug and Alcohol Dependence (2021) Vol. 231, pp. 109241-109241
Open Access | Times Cited: 11
Building an inpatient addiction medicine consult service in Sudbury, Canada: preliminary data and lessons learned in the era of COVID-19
Tara Leary, Natalie Aubin, David C. Marsh, et al.
Substance Abuse Treatment Prevention and Policy (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 4
A social network analysis approach to assess COVID19-related disruption to substance use treatment and informal social interactions among people who use drugs in Scotland
Mark McCann, Federica Bianchi, Srebrenka Letina, et al.
Addiction Science & Clinical Practice (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1

Scroll to top